# Yung Shin Pharmaceutical Industry Co., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/yung-shin-pharmaceutical-industry-co-ltd/231493b4-19d3-4045-807b-3b0108ce15ba

> Inspection records and compliance data for Yung Shin Pharmaceutical Industry Co., Ltd. in Taichung, 43769. Access full analysis and detailed observations.

---

## Details

- Name: Yung Shin Pharmaceutical Industry Co., Ltd.
- FEI Number: 3002808536
- City: Taichung
- State: 43769
- Country Name: Taiwan
- Address Line 1: Tachia
- Zip Code: Taiwan
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1238384 - Yung Shin Pharmaceutical Industry Co., Ltd. - 2024-04-25](https://www.keypedia.com/records/fda_inspections/yung-shin-pharmaceutical-industry-co-ltd/19516104-2382-42cb-9dc9-c0b447368ec2) — source: FDA, date: April 25, 2024
- [EIR - Yung Shin Pharmaceutical Industry Co., Ltd. - 2022-06-21](https://www.keypedia.com/records/eir/yung-shin-pharmaceutical-industry-co-ltd/305094de-2bac-4a6c-bd69-108d806f2364) — source: FDA, date: June 21, 2022
- [EIR - Yung Shin Pharmaceutical Industry Co., Ltd. - 2021-06-21](https://www.keypedia.com/records/eir/yung-shin-pharmaceutical-industry-co-ltd/3cfe7849-7804-4b9b-a644-098161ee5f25) — source: FDA, date: June 21, 2021
- [EIR - Yung Shin Pharmaceutical Industry Co., Ltd. - 2019-10-22](https://www.keypedia.com/records/eir/yung-shin-pharmaceutical-industry-co-ltd/ebf0f37a-87f7-472b-b85c-0645426077d8) — source: FDA, date: October 22, 2019
- [483 - Yung Shin Pharmaceutical Industry Co., Ltd. - 2019-10-22](https://www.keypedia.com/records/483/yung-shin-pharmaceutical-industry-co-ltd/ef7b4f8a-8ae0-4e34-97f5-460bf50e6f2b) — source: FDA, date: October 22, 2019
- [FDA Inspection 1111111 - Yung Shin Pharmaceutical Industry Co., Ltd. - 2019-10-22](https://www.keypedia.com/records/fda_inspections/yung-shin-pharmaceutical-industry-co-ltd/70db5627-a6bf-476a-ac8c-333f0c1f75dc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 22, 2019
- [EIR - Yung Shin Pharmaceutical Industry Co., Ltd. - 2019-09-12](https://www.keypedia.com/records/eir/yung-shin-pharmaceutical-industry-co-ltd/a44aaf11-ddd8-440b-a9aa-dac91953547c) — source: FDA, date: September 12, 2019
- [FDA Inspection 1062411 - Yung Shin Pharmaceutical Industry Co., Ltd. - 2018-07-27](https://www.keypedia.com/records/fda_inspections/yung-shin-pharmaceutical-industry-co-ltd/30efab8d-ed52-47f1-866b-2a7f1395efa7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 27, 2018
- [EMA GMP - Yung Shin Pharmaceutical Industry Co., Ltd. - Insp GMP 43237/10065539-0001 NCR - 2014-07-02](https://www.keypedia.com/records/ema/yung-shin-pharmaceutical-industry-co-ltd/bd380ec2-b9bd-40d0-83cb-a8971576cae0) — source: EMA, date: July 2, 2014
- [FDA Inspection 881288 - Yung Shin Pharmaceutical Industry Co., Ltd. - 2014-05-08](https://www.keypedia.com/records/fda_inspections/yung-shin-pharmaceutical-industry-co-ltd/d90a16d9-b10d-4925-8d13-1239ace187b9) — classification: No Action Indicated (NAI), source: FDA, date: May 8, 2014
- [FDA Inspection 854617 - Yung Shin Pharmaceutical Industry Co., Ltd. - 2013-08-16](https://www.keypedia.com/records/fda_inspections/yung-shin-pharmaceutical-industry-co-ltd/8c172bd8-52c2-41f0-a04d-68c183dcab20) — classification: No Action Indicated (NAI), source: FDA, date: August 16, 2013
- [FDA Inspection 784073 - Yung Shin Pharmaceutical Industry Co., Ltd. - 2012-04-30](https://www.keypedia.com/records/fda_inspections/yung-shin-pharmaceutical-industry-co-ltd/5ec61da8-f144-491d-808f-8c8da335b35e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 30, 2012
- [FDA Inspection 653750 - Yung Shin Pharmaceutical Industry Co., Ltd. - 2010-02-05](https://www.keypedia.com/records/fda_inspections/yung-shin-pharmaceutical-industry-co-ltd/babf4576-c33b-42c6-9318-d3d5bfba7cab) — classification: No Action Indicated (NAI), source: FDA, date: February 5, 2010

## Related Companies

- [Gemini Pharmaceuticals, Inc.](https://www.keypedia.com/companies/gemini-pharmaceuticals-inc/9e83f65c-3863-4ad6-a434-b37d9673ac0f)
- [ADMA Biologics, Inc](https://www.keypedia.com/companies/adma-biologics-inc/dcb996fb-4a71-44fe-87f1-cfe3979d4182)
- [LiquidCapsule Manufacturing, LLC](https://www.keypedia.com/companies/liquidcapsule-manufacturing-llc/48ffd682-de13-45a1-a478-7b15ac580830)
- [Haw Par Healthcare Limited](https://www.keypedia.com/companies/haw-par-healthcare-limited/4624588e-3f62-4c4c-8ea2-297ba6465337)
- [Lonza Tampa LLC](https://www.keypedia.com/companies/lonza-tampa-llc/6ba00e57-ba56-45fd-9718-cb91a9b2458a)
- [BioConnection B.V.](https://www.keypedia.com/companies/bioconnection-bv/b119ef65-94a1-4beb-9c2a-940c44e6c06e)
- [Gadal Laboratories Inc.](https://www.keypedia.com/companies/gadal-laboratories-inc/ab020b2d-bc0c-4731-bc27-f75fc34163d4)
- [Spartan Chemical Co Inc](https://www.keypedia.com/companies/spartan-chemical-co-inc/96e5b21e-5d00-402a-a2ce-3c38c571a9b9)
- [Avadim Holdings Inc](https://www.keypedia.com/companies/avadim-holdings-inc/6dc31a43-08a1-4771-8f42-d6cca75dbc5b)
- [MEDGEL PRIVATE LIMITED](https://www.keypedia.com/companies/medgel-private-limited/726df899-b5d3-4a4d-b97b-0abe34dc7ea3)

## Related Officers

- [GDUFA Supervisory Investigator](https://www.keypedia.com/people/paul-c-mouris/0da88ac4-d475-412f-8505-5a43dc8aea41)
- [other](https://www.keypedia.com/people/kareem-neal/2a9889d7-5425-471f-94f2-968b6566907f)
- [Bijoy Panicker](https://www.keypedia.com/people/bijoy-panicker/1c6ec57f-e02e-49b8-8b59-1853f3d2947a)